Join

Store

Chapters

APIC Action Center

Our Action Center makes it easy to action send a relevant letter to your legislators in seconds.

Take Action Now
Menu
Back to Policy Updates

FDA/FTC Warn CBD Companies About Marketing Products for COVID-19

FDA/FTC Warn CBD Companies About Marketing Products for COVID-19

3/29/22 — The FDA issued warning letters jointly with the Federal Trade Commission to seven companies for selling CBD products using research studies to claim or imply misleadingly that their CBD products will cure, mitigate, treat or prevent COVID-19. Consumers concerned about COVID-19 should consult with their health care provider. The companies that received warning letters are:

The FDA has not approved or authorized any drug containing CBD for the treatment or prevention of COVID-19.